Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.

Abramson, Jeremy S

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. [electronic resource] - Cancer Sep 2010 - 4283-90 p. digital

Publication Type: Journal Article

0008-543X

10.1002/cncr.25278 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--analysis
Central Nervous System Neoplasms--drug therapy
Cyclophosphamide--analysis
Disease-Free Survival
Doxorubicin--analysis
Drug Administration Schedule
Female
Humans
Injections, Intravenous
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Prednisone--analysis
Recurrence
Risk
Rituximab
Vincristine--analysis